This may have been posted here some time ago but I came across this when looking at a trial currently being carried out in Greece as the the effectiveness of using T3 to treat Covid-19. (I also came across a trial of T3 for treating MS where T3 showed no adverse effects.)
It seems to be saying that previous RCTs were flawed and conclusions that T4/T3 therapy is no better than T4 monotherapy should not be used in treatment as this is not correct.